A flexible facility for genetic computation, including both ongoing software development and expansion of hardware resources, is essential for high throughput sequencing operations to succeed. As the technology is new and still evolving rapidly, different platforms are introduced two to three times per year, each requiring some adjustment in order to harness the data pipeline. Stable artifacts must be monitored and recorded in order to eliminate most false calls;annotated coding region and splice junctions must be updated periodically;putative discrepancies that change coding sense must be parsed from those that do not;and finally all calls must be validated or excluded from consideration. Once authentic causative or incidental mutations are established, the data must be ported to a permanent repository without the introduction of error by human operators. This repository, built during the first period of funding, is Mutagenetix. A parallel repository will be established for drosophila mutations. All of these tasks will fall within the purview of Core E. In addition. Core E will model mutagenesis to allow optimized use of ENU in somatic cell mutagenesis studies, to be carried out in Project 1, and in future projects. Core E will be supported by hardware that includes a two large (-3,000 node) Linux cluster computers at the Texas Advanced Computing Center (TACC), a smaller dedicated cluster devoted solely to mapping short reads, and servers that support Mutagenetix (now accessed approximately 3,000 times per month by approximately 1,000 independent users worldwide).

Public Health Relevance

Core E will use massively parallel computing to model mutagenesis and to find mutations that either impair the host response or create resistance to viral infection. This will contribute to the advancement of human health by pointing to drug targets: proteins that may be blocked or augmented in their activity to inhibit viral infections.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
United States
Zip Code
Goto, Akira; Okado, Kiyoshi; Martins, Nelson et al. (2018) The Kinase IKK? Regulates a STING- and NF-?B-Dependent Antiviral Response Pathway in Drosophila. Immunity 49:225-234.e4
Maeda, Kazuhiko; Akira, Shizuo (2017) Regulation of mRNA stability by CCCH-type zinc-finger proteins in immune cells. Int Immunol 29:149-155
Satoh, Takashi; Nakagawa, Katsuhiro; Sugihara, Fuminori et al. (2017) Identification of an atypical monocyte and committed progenitor involved in fibrosis. Nature 541:96-101
Kozaki, Tatsuya; Komano, Jun; Kanbayashi, Daiki et al. (2017) Mitochondrial damage elicits a TCDD-inducible poly(ADP-ribose) polymerase-mediated antiviral response. Proc Natl Acad Sci U S A 114:2681-2686
Mager, Lukas Franz; Koelzer, Viktor Hendrik; Stuber, Regula et al. (2017) The ESRP1-GPR137 axis contributes to intestinal pathogenesis. Elife 6:
Mussabekova, Assel; Daeffler, Laurent; Imler, Jean-Luc (2017) Innate and intrinsic antiviral immunity in Drosophila. Cell Mol Life Sci 74:2039-2054
Kuhn, Lauriane; Majzoub, Karim; Einhorn, Evelyne et al. (2017) Definition of a RACK1 Interaction Network in Drosophila melanogaster Using SWATH-MS. G3 (Bethesda) 7:2249-2258
Takahama, Michihiro; Fukuda, Mitsunori; Ohbayashi, Norihiko et al. (2017) The RAB2B-GARIL5 Complex Promotes Cytosolic DNA-Induced Innate Immune Responses. Cell Rep 20:2944-2954
Lamiable, Olivier; Arnold, Johan; de Faria, Isaque Joao da Silva et al. (2016) Analysis of the Contribution of Hemocytes and Autophagy to Drosophila Antiviral Immunity. J Virol 90:5415-5426
Marques, João T; Imler, Jean-Luc (2016) The diversity of insect antiviral immunity: insights from viruses. Curr Opin Microbiol 32:71-76

Showing the most recent 10 out of 87 publications